PHARMACIE REBEIX-DEMONPION : revenue, balance sheet and financial ratios

PHARMACIE REBEIX-DEMONPION is a French company founded 27 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in LIMOGES (87000), this company of category PME shows in 2023 a revenue of 2.0 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE REBEIX-DEMONPION (SIREN 420145088)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue N/C 2 016 541 € 1 860 993 € 1 669 650 € 1 682 556 € 1 670 724 € 1 595 502 € 1 538 988 € N/C
Net income 95 993 € 126 738 € 131 208 € 119 340 € 96 898 € 110 243 € 118 741 € 101 971 € 61 861 €
EBITDA N/C 176 048 € 163 429 € 155 724 € 112 414 € 120 891 € 139 110 € 130 985 € N/C
Net margin N/C 6.3% 7.1% 7.1% 5.8% 6.6% 7.4% 6.6% N/C

Revenue and income statement

In 2024, PHARMACIE REBEIX-DEMONPION generates positive net income of 96 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 62 k€ -> 96 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

95 993 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 5%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 82%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

5.36%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

82.35%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

38.1%

Solvency indicators evolution
PHARMACIE REBEIX-DEMONPION

Sector positioning

Debt ratio
5.36 2024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Excellent

In 2024, the debt ratio of PHARMACIE REBEIX-DEMONPION (5.36) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
82.35% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Excellent +9 pts over 3 years

In 2024, the financial autonomy of PHARMACIE REBEIX-DEMONPION (82.3%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Repayment capacity
1.03 years 2023
2022
2023
Q1: 0.95 years
Med: 3.59 years
Q3: 7.48 years
Good

In 2023, the repayment capacity of PHARMACIE REBEIX-DEMONPION (1.03) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 216.32. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

216.32

Liquidity indicators evolution
PHARMACIE REBEIX-DEMONPION

Sector positioning

Liquidity ratio
216.32 2024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Good +10 pts over 3 years

In 2024, the liquidity ratio of PHARMACIE REBEIX-DEMONPION (216.32) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Interest coverage
2.12x 2023
2022
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Average +17 pts over 2 years

In 2023, the interest coverage of PHARMACIE REBEIX-DEMONPION (2.1x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
PHARMACIE REBEIX-DEMONPION

Positioning of PHARMACIE REBEIX-DEMONPION in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of PHARMACIE REBEIX-DEMONPION is estimated at 1 340 133 € (range 933 247€ - 2 004 916€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
933k€ 1340k€ 2004k€
1 340 133 € Range: 933 247€ - 2 004 916€
NAF 5 année 2024

Valuation method used

Net Income Multiple
95 993 € × 14.0x = 1 340 133 €
Range: 933 248€ - 2 004 916€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE REBEIX-DEMONPION with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE REBEIX-DEMONPION

What is the revenue of PHARMACIE REBEIX-DEMONPION ?

The revenue of PHARMACIE REBEIX-DEMONPION in 2023 is 2.0 M€.

Is PHARMACIE REBEIX-DEMONPION profitable?

Yes, PHARMACIE REBEIX-DEMONPION generated a net profit of 96 k€ in 2024.

Where is the headquarters of PHARMACIE REBEIX-DEMONPION ?

The headquarters of PHARMACIE REBEIX-DEMONPION is located in LIMOGES (87000), in the department Haute-Vienne.

Where to find the tax return of PHARMACIE REBEIX-DEMONPION ?

The tax return of PHARMACIE REBEIX-DEMONPION is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE REBEIX-DEMONPION operate?

PHARMACIE REBEIX-DEMONPION operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.